Company
Cerevance
| Industry | focused on developing precision novel therapeutics for central nervous system (CNS) diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Cerevance | Series B-1 Funding | 2024-04-25 |
| Cerevance | Series B | 2023-02-13 |
Company
| Industry | focused on developing precision novel therapeutics for central nervous system (CNS) diseases |
|---|
| Company | Round | Date |
|---|---|---|
| Cerevance | Series B-1 Funding | 2024-04-25 |
| Cerevance | Series B | 2023-02-13 |